Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShort-Term Debt repayments
Ratios

National Research (NRC) EBIAT (2016 - 2025)

National Research (NRC) has disclosed EBIAT for 16 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • Quarterly EBIAT fell 72.59% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.6 million through Dec 2025, down 53.19% year-over-year, with the annual reading at $11.6 million for FY2025, 53.19% down from the prior year.
  • EBIAT hit $1.8 million in Q4 2025 for National Research, down from $4.1 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $9.7 million in Q3 2021 to a low of -$106000.0 in Q2 2025.
  • Historically, EBIAT has averaged $6.8 million across 5 years, with a median of $7.1 million in 2023.
  • Biggest five-year swings in EBIAT: surged 33.38% in 2023 and later plummeted 101.72% in 2025.
  • Year by year, EBIAT stood at $9.6 million in 2021, then tumbled by 31.06% to $6.6 million in 2022, then skyrocketed by 33.38% to $8.9 million in 2023, then decreased by 25.94% to $6.6 million in 2024, then plummeted by 72.59% to $1.8 million in 2025.
  • Business Quant data shows EBIAT for NRC at $1.8 million in Q4 2025, $4.1 million in Q3 2025, and -$106000.0 in Q2 2025.